ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,428.38
0.03%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Laboratory Corporation of America Holdings (LH)

  7. Laboratory Corporation of America Holdings (LH) Noticias

LH Laboratory Corporation of America Holdings

198.40
0.05 (0.03%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Laboratory Corporation of America Holdings LH NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 0.03% 198.40 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
197.08 197.01 200.155 198.40 198.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202405:58PRNUSLabcorp Announces 2024 First Quarter Results
24/4/202420:27PRNUSLabcorp Announces Winning Bid for Select Assets of Invitae
24/4/202420:19PRNUSInvitae Enters into Agreement with Labcorp for Sale of..
15/4/202406:00PRNUSLabcorp Announces First-of-Its-Kind Test for Early..
11/4/202405:59PRNUSLabcorp Declares Quarterly Dividend
10/4/202405:49PRNUSLabcorp Receives FDA Emergency Use Authorization for Mpox..
08/4/202406:00PRNUSLabcorp Announces Expansion of Precision Oncology Portfolio..
05/4/202406:00PRNUSLabcorp Launches Labcorp® Plasma Detect™ Extending..
02/4/202406:00PRNUSLabcorp to Present Diverse Portfolio of Precision Oncology..
01/4/202407:00BWXcell Biosciences Strengthens Cell and Gene Therapy..
29/3/202408:00PRNUSThe Prelude Network® Names Labcorp Its Preferred Genetic..
28/3/202407:00PRNUSLabcorp Announces Acquisition of Select Assets of..
27/3/202406:00PRNUSLabcorp to Announce First Quarter Financial Results on April..
20/3/202406:00PRNUSLabcorp Launches pTau217 Blood Biomarker Test to Accelerate..
16/3/202409:29PRNUSLabcorp Presents New Research Demonstrating Clinical Impact..
11/3/202407:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202412:16EDGAR2Form 144 - Report of proposed sale of securities
07/3/202409:34EDGAR2Form 144 - Report of proposed sale of securities
07/3/202406:00PRNUSLabcorp Launches Weight Loss Management Testing Solutions
22/2/202414:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202414:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:35EDGAR2Form 144 - Report of proposed sale of securities
21/2/202413:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202407:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
15/2/202407:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202406:01EDGAR2Form 8-K - Current report
15/2/202405:56PRNUSLabcorp Announces 2023 Fourth Quarter and Full Year Results
13/2/202411:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202411:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202409:24EDGAR2Form 144 - Report of proposed sale of securities
09/2/202411:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202414:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NYSE
LH
Laboratory Corporation o...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados